A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Allogene Therapeutics
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
University of Liverpool
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
TCR2 Therapeutics
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Lymphoma Study Association
M.D. Anderson Cancer Center
Massachusetts General Hospital
CTI BioPharma
Gruppo Italiano Studio Linfomi
Lymphoma Study Association